Last reviewed · How we verify
Humatrope
Humatrope is a Small molecule drug developed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). It is currently FDA-approved. Also known as: LY137998, Somatropin, Growth hormone, recombinant human growth hormone.
At a glance
| Generic name | Humatrope |
|---|---|
| Also known as | LY137998, Somatropin, Growth hormone, recombinant human growth hormone, Growth Hormone |
| Sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
- ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly (PHASE2)
- Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency (PHASE3)
- Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) (PHASE2)
- Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) (PHASE4)
- Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) (PHASE1, PHASE2)
- Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance (PHASE2)
- A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Humatrope CI brief — competitive landscape report
- Humatrope updates RSS · CI watch RSS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) portfolio CI
Frequently asked questions about Humatrope
What is Humatrope?
Humatrope is a Small molecule drug developed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Who makes Humatrope?
Humatrope is developed and marketed by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (see full Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline at /company/eunice-kennedy-shriver-national-institute-of-child-health-and-human-development).
Is Humatrope also known as anything else?
Humatrope is also known as LY137998, Somatropin, Growth hormone, recombinant human growth hormone, Growth Hormone.
What development phase is Humatrope in?
Humatrope is FDA-approved (marketed).
Related
- Manufacturer: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: LY137998, Somatropin, Growth hormone, recombinant human growth hormone, Growth Hormone
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing